Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Atorvastatin added to ARB therapy for sympathetic activity in hypertensive chronic kidney disease
2009-009334-32Phase 4Completed
- Sponsor
- University Medical Center Utrecht
- Start
- Feb 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of atorvastatin in chronic kidney disease (CKD) and hypertension (HTN) (2 arms), sponsored by University Medical Center Utrecht. Primary endpoint: muscle sympathetic nerve activity. Started Feb 2009; status: completed.
02
Drugs
atorvastatin
03
Conditions
chronic kidney disease (CKD)hypertension (HTN)
Beyond the preview
Go deeper on 2009-009334-32.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-009334-32.